 | • レポートコード：QYR9ST01633 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の神経芽腫治療市場について調査・分析し、以下の構成でお届け致します。神経芽腫治療の種類別には、併用化学療法、モノクローナル抗体療法、ワクチン療法、その他に、用途別には、病院、診療所、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別神経芽腫治療売上データ ・地域別神経芽腫治療市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別神経芽腫治療市場規模：併用化学療法、モノクローナル抗体療法、ワクチン療法、その他 ・用途別神経芽腫治療市場規模：病院、診療所、その他 ・主要メーカーの企業情報：Seattle Children’s、CureSearch、Texas Children’s、NANT ・神経芽腫治療の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Neuroblastoma (NB) is the most common cancer in childhood and infancy. Neuroblastoma is a cancer that starts in primitive nerve cells. It rarely occurs after age around 10 years. Neuroblastoma is sometimes caused by a gene mutation passed from the parent to the child. The global Neuroblastoma Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Neuroblastoma Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Neuroblastoma Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neuroblastoma Treatment in these regions.
This research report categorizes the global Neuroblastoma Treatment market by top players/brands, region, type and end user. This report also studies the global Neuroblastoma Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Seattle Children’s
CureSearch
Texas Children’s
NANT
Market size by Product
Combination Chemotherapy
Monoclonal Antibody Therapy
Vaccine Therapy
Others
Market size by End User
Hospitals
Clinics
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Neuroblastoma Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Neuroblastoma Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Neuroblastoma Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Neuroblastoma Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Neuroblastoma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neuroblastoma Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Neuroblastoma Treatment Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Neuroblastoma Treatment Market Size Growth Rate by Product
1.4.2 Combination Chemotherapy
1.4.3 Monoclonal Antibody Therapy
1.4.4 Vaccine Therapy
1.4.5 Others
1.5 Market by End User
1.5.1 Global Neuroblastoma Treatment Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Neuroblastoma Treatment Market Size
2.1.1 Global Neuroblastoma Treatment Revenue 2014-2025
2.1.2 Global Neuroblastoma Treatment Sales 2014-2025
2.2 Neuroblastoma Treatment Growth Rate by Regions
2.2.1 Global Neuroblastoma Treatment Sales by Regions
2.2.2 Global Neuroblastoma Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Neuroblastoma Treatment Sales by Manufacturers
3.1.1 Neuroblastoma Treatment Sales by Manufacturers
3.1.2 Neuroblastoma Treatment Sales Market Share by Manufacturers
3.1.3 Global Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Neuroblastoma Treatment Revenue by Manufacturers
3.2.1 Neuroblastoma Treatment Revenue by Manufacturers (2014-2019)
3.2.2 Neuroblastoma Treatment Revenue Share by Manufacturers (2014-2019)
3.3 Neuroblastoma Treatment Price by Manufacturers
3.4 Neuroblastoma Treatment Manufacturing Base Distribution, Product Types
3.4.1 Neuroblastoma Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neuroblastoma Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Neuroblastoma Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Neuroblastoma Treatment Sales by Product
4.2 Global Neuroblastoma Treatment Revenue by Product
4.3 Neuroblastoma Treatment Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Neuroblastoma Treatment Breakdown Data by End User
6 North America
6.1 North America Neuroblastoma Treatment by Countries
6.1.1 North America Neuroblastoma Treatment Sales by Countries
6.1.2 North America Neuroblastoma Treatment Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Neuroblastoma Treatment by Product
6.3 North America Neuroblastoma Treatment by End User
7 Europe
7.1 Europe Neuroblastoma Treatment by Countries
7.1.1 Europe Neuroblastoma Treatment Sales by Countries
7.1.2 Europe Neuroblastoma Treatment Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neuroblastoma Treatment by Product
7.3 Europe Neuroblastoma Treatment by End User
8 Asia Pacific
8.1 Asia Pacific Neuroblastoma Treatment by Countries
8.1.1 Asia Pacific Neuroblastoma Treatment Sales by Countries
8.1.2 Asia Pacific Neuroblastoma Treatment Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Neuroblastoma Treatment by Product
8.3 Asia Pacific Neuroblastoma Treatment by End User
9 Central & South America
9.1 Central & South America Neuroblastoma Treatment by Countries
9.1.1 Central & South America Neuroblastoma Treatment Sales by Countries
9.1.2 Central & South America Neuroblastoma Treatment Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Neuroblastoma Treatment by Product
9.3 Central & South America Neuroblastoma Treatment by End User
10 Middle East and Africa
10.1 Middle East and Africa Neuroblastoma Treatment by Countries
10.1.1 Middle East and Africa Neuroblastoma Treatment Sales by Countries
10.1.2 Middle East and Africa Neuroblastoma Treatment Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Neuroblastoma Treatment by Product
10.3 Middle East and Africa Neuroblastoma Treatment by End User
11 Company Profiles
11.1 Seattle Children’s
11.1.1 Seattle Children’s Company Details
11.1.2 Company Business Overview
11.1.3 Seattle Children’s Neuroblastoma Treatment Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Seattle Children’s Neuroblastoma Treatment Products Offered
11.1.5 Seattle Children’s Recent Development
11.2 CureSearch
11.2.1 CureSearch Company Details
11.2.2 Company Business Overview
11.2.3 CureSearch Neuroblastoma Treatment Sales, Revenue and Gross Margin (2014-2019)
11.2.4 CureSearch Neuroblastoma Treatment Products Offered
11.2.5 CureSearch Recent Development
11.3 Texas Children’s
11.3.1 Texas Children’s Company Details
11.3.2 Company Business Overview
11.3.3 Texas Children’s Neuroblastoma Treatment Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Texas Children’s Neuroblastoma Treatment Products Offered
11.3.5 Texas Children’s Recent Development
11.4 NANT
11.4.1 NANT Company Details
11.4.2 Company Business Overview
11.4.3 NANT Neuroblastoma Treatment Sales, Revenue and Gross Margin (2014-2019)
11.4.4 NANT Neuroblastoma Treatment Products Offered
11.4.5 NANT Recent Development
12 Future Forecast
12.1 Neuroblastoma Treatment Market Forecast by Regions
12.1.1 Global Neuroblastoma Treatment Sales Forecast by Regions 2019-2025
12.1.2 Global Neuroblastoma Treatment Revenue Forecast by Regions 2019-2025
12.2 Neuroblastoma Treatment Market Forecast by Product
12.2.1 Global Neuroblastoma Treatment Sales Forecast by Product 2019-2025
12.2.2 Global Neuroblastoma Treatment Revenue Forecast by Product 2019-2025
12.3 Neuroblastoma Treatment Market Forecast by End User
12.4 North America Neuroblastoma Treatment Forecast
12.5 Europe Neuroblastoma Treatment Forecast
12.6 Asia Pacific Neuroblastoma Treatment Forecast
12.7 Central & South America Neuroblastoma Treatment Forecast
12.8 Middle East and Africa Neuroblastoma Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neuroblastoma Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Neuroblastoma Treatment Product Picture
Table Neuroblastoma Treatment Market Segments
Table Key Manufacturers Neuroblastoma Treatment Covered
Table Global Neuroblastoma Treatment Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Neuroblastoma Treatment Sales Market Share by Product 2014-2025
Figure Combination Chemotherapy Product Picture
Table Major Manufacturers of Combination Chemotherapy
Figure Monoclonal Antibody Therapy Product Picture
Table Major Manufacturers of Monoclonal Antibody Therapy
Figure Vaccine Therapy Product Picture
Table Major Manufacturers of Vaccine Therapy
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Neuroblastoma Treatment Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Others
Figure Neuroblastoma Treatment Report Years Considered
Figure Global Neuroblastoma Treatment Market Size 2014-2025 (Million US$)
Figure Global Neuroblastoma Treatment Sales 2014-2025 (K Units)
Table Global Neuroblastoma Treatment Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Neuroblastoma Treatment Sales by Regions 2014-2019 (K Units)
Table Global Neuroblastoma Treatment Sales Market Share by Regions 2014-2019
Figure Global Neuroblastoma Treatment Sales Market Share by Regions 2014-2019
Figure 2018 Global Neuroblastoma Treatment Sales Market Share by Regions
Table Global Neuroblastoma Treatment Revenue by Regions 2014-2019 (Million US$)
Table Global Neuroblastoma Treatment Revenue Market Share by Regions 2014-2019
Figure Global Neuroblastoma Treatment Revenue Market Share by Regions 2014-2019
Figure 2018 Global Neuroblastoma Treatment Revenue Market Share by Regions
Table Global Neuroblastoma Treatment Sales by Manufacturers (2014-2019) (K Units)
Table Global Neuroblastoma Treatment Sales Share by Manufacturers (2014-2019)
Figure Global Neuroblastoma Treatment Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Neuroblastoma Treatment Revenue by Manufacturers (2014-2019) (Million USD)
Table Neuroblastoma Treatment Revenue Share by Manufacturers (2014-2019)
Figure Neuroblastoma Treatment Value Share by Manufacturers in 2018
Table Key Manufacturers Neuroblastoma Treatment Price (2014-2019) (USD/Unit)
Table Neuroblastoma Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Neuroblastoma Treatment Product Type
Table Date of International Manufacturers Enter into Neuroblastoma Treatment Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Neuroblastoma Treatment Sales by Product (2014-2019) (K Units)
Table Global Neuroblastoma Treatment Sales Share by Product (2014-2019)
Figure Global Neuroblastoma Treatment Sales Market Share by Product (2014-2019)
Figure Global Neuroblastoma Treatment Sales Market Share by Product in 2018
Table Global Neuroblastoma Treatment Revenue by Product (2014-2019) (Million US$)
Table Global Neuroblastoma Treatment Revenue Share by Product (2014-2019)
Figure Global Neuroblastoma Treatment Revenue Market Share by Product (2014-2019)
Figure Global Neuroblastoma Treatment Revenue Market Share by Product in 2018
Table Neuroblastoma Treatment Price by Product 2014-2019 (USD/Unit)
Table Global Neuroblastoma Treatment Sales by End User (2014-2019) (K Units)
Table Global Neuroblastoma Treatment Sales Share by End User (2014-2019)
Figure Global Sales Neuroblastoma Treatment Market Share by End User (2014-2019)
Figure Global Sales Neuroblastoma Treatment Market Share by End User in 2018
Figure North America Neuroblastoma Treatment Sales Growth Rate 2014-2019 (K Units)
Figure North America Neuroblastoma Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table North America Neuroblastoma Treatment Sales by Countries (2014-2019) (K Units)
Table North America Neuroblastoma Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 North America Neuroblastoma Treatment Sales Market Share by Countries
Table North America Neuroblastoma Treatment Revenue by Countries (2014-2019) (Million US$)
Table North America Neuroblastoma Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Neuroblastoma Treatment Revenue Market Share by Countries
Figure United States Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure United States Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Canada Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table North America Neuroblastoma Treatment Sales by Product (2014-2019) (K Units)
Table North America Neuroblastoma Treatment Sales Market Share by Product (2014-2019)
Figure 2018 North America Neuroblastoma Treatment Market Share by Product
Table North America Neuroblastoma Treatment Sales by End User (2014-2019) (K Units)
Table North America Neuroblastoma Treatment Sales Market Share by End User (2014-2019)
Figure 2018 North America Neuroblastoma Treatment Market Share by End User
Figure Europe Neuroblastoma Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Europe Neuroblastoma Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Neuroblastoma Treatment Sales by Countries (2014-2019) (K Units)
Table Europe Neuroblastoma Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Neuroblastoma Treatment Sales Market Share by Countries
Table Europe Neuroblastoma Treatment Revenue by Countries (2014-2019) (Million US$)
Table Europe Neuroblastoma Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Neuroblastoma Treatment Revenue Market Share by Countries
Figure Germany Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Germany Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure France Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure France Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure UK Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Italy Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Russia Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Neuroblastoma Treatment Sales by Product (2014-2019) (K Units)
Table Europe Neuroblastoma Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Europe Neuroblastoma Treatment Market Share by Product
Table Europe Neuroblastoma Treatment Sales by End User (2014-2019) (K Units)
Table Europe Neuroblastoma Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Europe Neuroblastoma Treatment Market Share by End User
Figure Asia Pacific Neuroblastoma Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Neuroblastoma Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Neuroblastoma Treatment Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Neuroblastoma Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Neuroblastoma Treatment Sales Market Share by Countries
Table Asia Pacific Neuroblastoma Treatment Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Neuroblastoma Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Neuroblastoma Treatment Revenue Market Share by Countries
Figure China Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure China Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Japan Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Korea Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure India Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure India Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Australia Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Neuroblastoma Treatment Sales by Product (2014-2019) (K Units)
Table Asia Pacific Neuroblastoma Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Neuroblastoma Treatment Market Share by Product
Table Asia Pacific Neuroblastoma Treatment Sales by End User (2014-2019) (K Units)
Table Asia Pacific Neuroblastoma Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Neuroblastoma Treatment Market Share by End User
Figure Central & South America Neuroblastoma Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Neuroblastoma Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Neuroblastoma Treatment Sales by Countries (2014-2019) (K Units)
Table Central & South America Neuroblastoma Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Neuroblastoma Treatment Sales Market Share by Countries
Table Central & South America Neuroblastoma Treatment Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Neuroblastoma Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Neuroblastoma Treatment Revenue Market Share by Countries
Figure Brazil Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Neuroblastoma Treatment Sales by Product (2014-2019) (K Units)
Table Central & South America Neuroblastoma Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Neuroblastoma Treatment Market Share by Product
Table Central & South America Neuroblastoma Treatment Sales by End User (2014-2019) (K Units)
Table Central & South America Neuroblastoma Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Neuroblastoma Treatment Market Share by End User
Figure Middle East and Africa Neuroblastoma Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Neuroblastoma Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Neuroblastoma Treatment Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Neuroblastoma Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Neuroblastoma Treatment Sales Market Share by Countries
Table Middle East and Africa Neuroblastoma Treatment Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Neuroblastoma Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Neuroblastoma Treatment Revenue Market Share by Countries
Figure GCC Countries Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Neuroblastoma Treatment Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Neuroblastoma Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Neuroblastoma Treatment Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Neuroblastoma Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Neuroblastoma Treatment Market Share by Product
Table Middle East and Africa Neuroblastoma Treatment Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Neuroblastoma Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Neuroblastoma Treatment Market Share by End User
Table Seattle Children’s Company Details
Table Seattle Children’s Neuroblastoma Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Seattle Children’s Recent Development
Table CureSearch Company Details
Table CureSearch Neuroblastoma Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table CureSearch Recent Development
Table Texas Children’s Company Details
Table Texas Children’s Neuroblastoma Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Texas Children’s Recent Development
Table NANT Company Details
Table NANT Neuroblastoma Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table NANT Recent Development
Table Global Neuroblastoma Treatment Sales Forecast by Regions 2019-2025 (K Units)
Table Global Neuroblastoma Treatment Sales Market Share Forecast by Regions 2019-2025
Table Global Neuroblastoma Treatment Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Neuroblastoma Treatment Revenue Market Share Forecast by Regions 2019-2025
Table Global Neuroblastoma Treatment Sales Forecast by Product 2019-2025 (K Units)
Table Global Neuroblastoma Treatment Sales Market Share Forecast by Product 2019-2025
Table Global Neuroblastoma Treatment Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Neuroblastoma Treatment Revenue Market Share Forecast by Product 2019-2025
Table Global Neuroblastoma Treatment Sales Forecast by End User 2019-2025 (K Units)
Table Global Neuroblastoma Treatment Sales Market Share Forecast by End User 2019-2025
Figure North America Neuroblastoma Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Neuroblastoma Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Neuroblastoma Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Neuroblastoma Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Neuroblastoma Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Neuroblastoma Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Neuroblastoma Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Neuroblastoma Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Neuroblastoma Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Neuroblastoma Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Neuroblastoma Treatment Value Chain
Table Neuroblastoma Treatment Customers List
Table Neuroblastoma Treatment Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
癌温熱療法の世界市場：インサイト・予測 The global Hyperthermia Treatment for Cancer market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hyperthermia Treatment for Cancer market based o…- モノクローナル抗体治療薬の世界市場：インサイト・予測 For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body.T…
- 結核ワクチン治療の世界市場：市場規模・現状・予測 Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …
- 結核ワクチン治療の世界市場：市場規模・現状・予測 Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …
- 糖尿病性足潰瘍の治療の世界市場：インサイト・予測 Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper tre…